Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies
about
Inhibitory antibodies targeting emerging viruses: advancements and mechanismsA CRISPR toolbox to study virus-host interactionsMapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular EntryA "Trojan horse" bispecific-antibody strategy for broad protection against ebolavirusesIn silico and in vitro methods to identify ebola virus VP35-dsRNA inhibitorsFighting Ebola: A Window for Vaccine Re-evaluation?Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding SiteA Single Residue in Ebola Virus Receptor NPC1 Influences Cellular Host Range in Reptiles.Structures of Ebola virus GP and sGP in complex with therapeutic antibodies.Spontaneous Mutation at Amino Acid 544 of the Ebola Virus Glycoprotein Potentiates Virus Entry and Selection in Tissue Culture.Ebola Virus Disease in Humans: Pathophysiology and Immunity.Host Factors Involved in Ebola Virus Replication.Functional mutations in spike glycoprotein of Zaire ebolavirus associated with an increase in infection efficiency.Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of Vulnerability.Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses.Filovirus Structural Biology: The Molecules in the Machine.Computational analysis of envelope glycoproteins from diverse geographical isolates of bovine leukemia virus identifies highly conserved peptide motifs.The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding.Design and evaluation of bi- and trispecific antibodies targeting multiple filovirus glycoproteins.Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola VirusThe structural basis for filovirus neutralization by monoclonal antibodiesSystematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to ProtectionMultifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus GlycoproteinAsymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan capPan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection SurvivorsStructural Basis of Pan-Ebolavirus Neutralization by a Human Antibody against a Conserved, yet Cryptic EpitopeStructural Basis of Pan-Ebolavirus Neutralization by an Antibody Targeting the Glycoprotein Fusion Loop
P2860
Q24289645-1DE275AC-AFE8-415B-A22F-64066EA4F0CEQ29994612-2DA9E6CB-2258-4CB8-A384-4AB4F39BEE5CQ30276615-32C53DFA-AFCC-470C-9B31-DC3722475590Q34539842-D519F980-A44E-4792-9E8A-8846939D67F6Q36136841-CD5EE08F-126C-45E4-950F-D9439CAF437FQ36247762-E88687F2-F2E6-409F-BC3C-A52214D6FDA3Q36913606-B6C8D1BE-5434-4B89-856E-8A3BA8C27EBDQ36973175-77AF7F7B-E3BD-41A4-ADE5-93B5E328D956Q37213985-23B9B119-2FD7-412E-AED8-65B2606E3E34Q38702384-6EB4F8EF-E3C5-4666-BC42-A124E6440572Q38707770-9CDF4782-F30F-4A34-BCD8-D89DA0058B61Q39436358-DF46BCBC-8F26-4CFA-9ED0-548A250636BEQ39540578-1C124303-2559-47C3-A4E9-FA6BA066CE7EQ40056179-B92B458D-EC65-40CF-913A-5713CDBAF57AQ40056187-A8EB995D-0D77-4AA3-BF93-53D250427BA6Q40088356-63D780CF-25AF-4DCA-B043-72658CD3826CQ47196175-C0A944F6-B524-429F-A069-2F8A8B3B612CQ47555346-7EB9902C-8A9B-4F55-A952-AE94A40053FDQ51784478-BEA0165A-A704-48DC-93DA-CE3CB3C3D5B9Q56535662-E56DAE81-B045-44F1-92AD-1D45E6F722A8Q56536340-8891D437-8B46-4586-82C5-FEF06DEC5246Q56558172-A54D9CFA-FD3D-44EB-B2AC-9F6B04EA189FQ56897586-35FBA3CE-DEC3-4F25-A9F5-4BE112B22E32Q56999931-8C25464C-5569-40FF-A6C2-47433999251EQ57092281-AF281DB7-E1A1-4478-84C1-2C69042778D1Q57255383-36372C41-C2FB-4397-9AFF-A35F1B13A4B3Q58764092-85EAFFA3-B687-4B73-BD10-7F051318BF3D
P2860
Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Host-Primed Ebola Virus GP Exp ...... roadly Neutralizing Antibodies
@ast
Host-Primed Ebola Virus GP Exp ...... roadly Neutralizing Antibodies
@en
Host-Primed Ebola Virus GP Exp ...... roadly Neutralizing Antibodies
@nl
type
label
Host-Primed Ebola Virus GP Exp ...... roadly Neutralizing Antibodies
@ast
Host-Primed Ebola Virus GP Exp ...... roadly Neutralizing Antibodies
@en
Host-Primed Ebola Virus GP Exp ...... roadly Neutralizing Antibodies
@nl
prefLabel
Host-Primed Ebola Virus GP Exp ...... roadly Neutralizing Antibodies
@ast
Host-Primed Ebola Virus GP Exp ...... roadly Neutralizing Antibodies
@en
Host-Primed Ebola Virus GP Exp ...... roadly Neutralizing Antibodies
@nl
P2860
P50
P921
P3181
P356
P1433
P1476
Host-Primed Ebola Virus GP Exp ...... roadly Neutralizing Antibodies
@en
P2093
Kartik Chandran
Shridhar Bale
P2860
P304
P3181
P356
10.1128/MBIO.02154-15
10.2210/PDB5HJ3/PDB
P50
P577
2016-02-23T00:00:00Z